Test
211 articles
A Maintenance Trial for Patients with BRCA or PALB2 Mutations
A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.
A Second Opinion Changes the Pancreatic Cancer Game Plan
Gregg Wittman’s doctors diagnosed him with stage IV pancreatic cancer, but could never get a good biopsy; a second opinion figured out the reason.
Trusting My Gut
Marla Schreffler had a feeling something was wrong, even after she got her diabetes diagnosis. Further tests confirmed that she had pancreatic cancer.
Personalizing Pancreatic Cancer Treatment
Dr. Mark Ricigliano takes a closer look at the genetics of circulating tumor cells, to personalize pancreatic cancer treatment for the best results.
A Second Opinion Leads to Hope for the Future
Leanne Pierce decided to go to a major cancer center for a second opinion after her pancreatic cancer diagnosis.
Buying Time for Another Clinical Trial
Richard Valdes has alternated standard pancreatic cancer treatments with clinical trials of immunotherapy and a pancreatic vaccine during his treatment.
The Impact of BRCA Is Broader Than Breast and Ovarian Cancer
Rona Greenberg discusses the impact of BRCA2 on her family, and her search for the best clinical trial for her needs after her pancreatic cancer diagnosis.
Don’t Give Up
Joe Pearson responded so well to chemotherapy that even with a stage III tumor near a blood vessel he was able to have Whipple surgery.
Have Hope
Andy Seynaeve has undergone many rounds of chemotherapy but he has had a great response. Best of all, he has hope.
Genetic Testing Leads Me to a PARP Inhibitor Trial
Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial.
A Big Teaching Hospital Can Make All the Difference
When Bob Tirk’s local doctor couldn’t figure out the source of his pain, he went to a large teaching hospital, where he was treated for pancreatic cancer.
A Clinical Trial Matches My Genetics
Steven Merlin learned that he carried the BRCA2 mutation after he developed pancreatic cancer. He researched and found a clinical trial for BRCA carriers.
Taking a Different Approach to Pancreatic Cancer Treatment
When Dr. Stephen Bigelsen was diagnosed with stage IV pancreatic cancer, he found a doctor to created a personalized treatment plan.
Working with Oncologists Willing to Take Risks
Anne Glauber chooses the new science of slow dosing of chemotherapy for her pancreatic treatment. She looks to developing science for future treatments.
Scanxiety—A Nearly Universal Experience Among Cancer Patients
Social worker Lauren Shaffer provides tips and insights into managing scanxiety, the worry that accompanies follow-up scans and tests for cancer patients.